Table 2.
Therapies and devices used by pediatric respondents to the questionnaire according to age group
| Therapies and devices | Age group | ||
|---|---|---|---|
| Group 1 (0–6 years; n = 85) | Group 2 (7–13 years; n = 423) | Group 3 (14–18 years; n = 390) | |
| Regular human insulin (IU/day) | 0 | 21.2 (12.3) | 30.6 (14.5) |
| Fast analog (IU/day) | 10.9 (9.0) | 24.6 (16.3) | 38.6 (19.9) |
| NPH (IU/day) | 7.6 (4.2) | 15.9 (9.4) | 24.8 (12.0) |
| Basal analog (IU/day) | 9.3 (9.3) | 27.9 (13.6) | 41.9 (16.5) |
| Pre-mixes (IU/day) | 0 | 37.4 (19.9) | 55.6 (21.15) |
| Total daily dose (IU/day) | 16.3 (12.2) | 21.2 (12.3) | 30.6 (14.5) |
| Injection device | |||
| Pens | 64.6% | 86.2% | 89.4% |
| 4-mm needles | 66.7% | 54.1% | 38.5% |
| 5-mm needles | 15.7% | 16.9% | 26.5% |
| 6-mm needles | 15.7% | 16.2% | 22.3% |
| 8-mm needles | 2.0% | 12.8% | 12.7% |
Values in table are presented as the mean with the SD in parenthesis or as the percentage, where appropriate
NPH neutral protamine Hagedorn (Insulin N)